The intense desire for a “cure” in individuals with spinal cord injury (SCI) has resulted in the transplantation of stem cells and embryonic and other cell types into the injured spinal cord to enable limb function. We review the ethical issues concerning the procurement and use of embryonic stem cells. A brief survey of the current state of human SCI transplantation is presented. We explore the interface between basic science and the clinical management of SCI and discuss the ethical issues of therapy. At what point is it ethical to conduct human experiments when the experimental data is still at an early stage of development? Is it ethical to perform these operations on a vulnerable group of patients without adequate scientific controls and analysis of the results? Motor neuroprosthetics is developing rapidly and will enable limb movement controlled by the paralyzed patient and other device control such as wheelchairs and communication boards. How can there be a more equitable distribution of such expensive technology and other treatments of SCI? Both clinicians and scientists should be mindful of these complex ethical issues when undertaking pioneering therapies for patients with SCI.

Enzmann GU, Benton RL, Talbott JF, Cao Q, Whittemore SR. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma. 2006;23(3–4):479–495.
Functional considerations of stem cell transplantation therapy for spinal cord repair
J Neurotrauma
, vol. 
23
 (pg. 
479
-
495
)
Garbossa D, Fontanella M, Fronda C, et al. New strategies for repairing the injured spinal cord: the role of stem cells. Neurol Res. 2006;28(5):500–504.
New strategies for repairing the injured spinal cord: the role of stem cells
Neurol Res.
, vol. 
28
 (pg. 
500
-
504
)
Nomura H, Tator CH, Shoichet MS. Bioengineered strategies for spinal cord repair. J Neurotrauma. 2006;23(3-4):496–507.
Bioengineered strategies for spinal cord repair
J Neurotrauma
, vol. 
23
 (pg. 
496
-
507
)
Reeve C. Nothing is Impossible. Reflections on a New Life. London: Century; 2002.
Nothing is Impossible. Reflections on a New Life
Findikli N, Candan NZ, Kahraman S. Human embryonic stem cell culture: current limitations and novel strategies. Reprod Biomed Online. 2006;13(4):581–590.
Human embryonic stem cell culture: current limitations and novel strategies
Reprod Biomed Online
, vol. 
13
 (pg. 
581
-
590
)
Krencik R, Zhang SC. Stem cell neural differentiation: a model for chemical biology. Curr Opin Chem Biol. 2006;10(6):592–597.
Stem cell neural differentiation: a model for chemical biology
Curr Opin Chem Biol.
, vol. 
10
 (pg. 
592
-
597
)
Evers K. European perspectives on therapeutic cloning. N Engl J Med. 2002;346(20):1579–1582.
European perspectives on therapeutic cloning
N Engl J Med.
, vol. 
346
 (pg. 
1579
-
1582
)
Cogle CR, Guthrie SM, Sanders RC, Allen WL, Scott EW, Petersen BE. An overview of stem cell research and regulatory issues. Mayo Clin Proc. 2003;78(8):993–1003.
An overview of stem cell research and regulatory issues
Mayo Clin Proc.
, vol. 
78
 (pg. 
993
-
1003
)
Ferretti P. Neural stem cell plasticity: recruitment of endogenous populations for regeneration. Curr Neurovasc Res. 2004;1(3):215–229.
Neural stem cell plasticity: recruitment of endogenous populations for regeneration
Curr Neurovasc Res.
, vol. 
1
 (pg. 
215
-
229
)
Johkura K, Cui L, Suzuki A, et al. Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants. Cardiovasc Res. 2003;58(2):435–443.
Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants
Cardiovasc Res.
, vol. 
58
 (pg. 
435
-
443
)
Nadal-Ginard B, Torella D, Ellison G. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to humans.] Rev Esp Cardiol. 2006;59(11):1175–1189.
[Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to humans.]
Rev Esp Cardiol
, vol. 
59
 (pg. 
1175
-
1189
)
Klein HM, Ghodsizad A, Marktanner R, et al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum. 2007;10(1):E66–69.
Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery
Heart Surg Forum
, vol. 
10
 (pg. 
E66
-
69
)
Melton DA. Reversal of type 1 diabetes in mice. N Engl J Med. 2006;355(1):89–90.
Reversal of type 1 diabetes in mice
N Engl J Med.
, vol. 
355
 (pg. 
89
-
90
)
Warnock M. A Question of Life: The Warnock Report on Human Fertilisation and Embryology. Oxford, UK, New York, NY: B. Blackwell; 1985.
A Question of Life: The Warnock Report on Human Fertilisation and Embryology
Australian Government. Research Involving Human Embryos Act, No. 145, 2002. Available at: http://scaleplus.law.gov.au/html/comact/11/6603/pdf/1452002.pdf http://scaleplus.law.gov.au/html/comact/11/6603/pdf/1452002.pdf
Acts of the UK Parliament. Human Fertilisation and Embryology Act 1990 (c. 37) 1990. Available at: http://www.opsi.gov.uk/acts/acts1990/Ukpga_19900037_en_1.htm http://www.opsi.gov.uk/acts/acts1990/Ukpga_19900037_en_1.htm
NHMRC. Licences granted for research using IVF embryos, 2004. Available at: http://www.nhmrc.gov.au/embryos/stemcells/index.htm http://www.nhmrc.gov.au/embryos/stemcells/index.htm
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385(6619):810–813.
Viable offspring derived from fetal and adult mammalian cells
Nature
, vol. 
385
 (pg. 
810
-
813
)
HFEA. HFEA grants the first therapeutic cloning licence for research, 2004. Available at: http://www.hfea.gov.uk/cps/rde/xchg/SID-3F57D79B-B06AEE07/hfea/hs.xsl/1048.htm http://www.hfea.gov.uk/cps/rde/xchg/SID-3F57D79B-B06AEE07/hfea/hs.xsl/1048.htm
Humphries G. Legislative Responses to Recommendations of the Lockhart Review. Canberra: Standing Committee on Community Affairs; 2006.
Knowles S. Provisions of the Research Involving Embryos and Prohibition of Human Cloning Bill, 2002. Canberra: Parliament of the Commonwealth of Australia; 2002.
Cyranoski D. Australia lifts ban on cloning. Nature. 2006;444(7121):799.
Australia lifts ban on cloning
Nature
, vol. 
444
 pg. 
799
 
Bobbert M. Ethical questions concerning research on human embryos, embryonic stem cells and chimeras. Biotechnol J. 2006;1(12):1352–1369.
Ethical questions concerning research on human embryos, embryonic stem cells and chimeras
Biotechnol J
, vol. 
1
 (pg. 
1352
-
1369
)
Rosenfeld JV, Gillett GR. Ethics, stem cells and spinal cord repair. Med J Aust. 2004;180(12):637–639.
Ethics, stem cells and spinal cord repair
Med J Aust.
, vol. 
180
 (pg. 
637
-
639
)
Hodaie M, Neimat JS, Lozano AM. The dopaminergic nigrostriatal system and Parkinson’s disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurgery. 2007;60(1):17–28; discussion 28–30.
The dopaminergic nigrostriatal system and Parkinson’s disease: molecular events in development, disease, and cell death, and new therapeutic strategies
Neurosurgery
, vol. 
60
 (pg. 
17
-
28
)
Hofstetter CP, Holmstrom NA, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8(3):346–353.
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome
Nat Neurosci.
, vol. 
8
 (pg. 
346
-
353
)
Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701–2711.
What makes clinical research ethical?
JAMA
, vol. 
283
 (pg. 
2701
-
2711
)
Macklin R. The ethical problems with sham surgery in clinical research. New Engl J Med. 1999;341(13):992–996.
The ethical problems with sham surgery in clinical research
New Engl J Med.
, vol. 
341
 (pg. 
992
-
996
)
Albin RL. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls. J Med Ethics. 2002;28(5):322–325.
Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls
J Med Ethics
, vol. 
28
 (pg. 
322
-
325
)
Langston JW, Widner H, Brooks D. Fahn S, Freeman T, Goetz C, Watts W. Core assessment program for intracerebral transplantation (CAPIT). In: Intracerebral Transplantation in Movement Disorders, Vol. 4. Amsterdam: Elsevier; 1991:227–241.
Intracerebral Transplantation in Movement Disorders, Vol. 4.
Core assessment program for intracerebral transplantation (CAPIT)
(pg. 
227
-
241
)
Steeves J, Fawcett J, Tuszynski M. Report of International Clinical Trials Workshop on Spinal Cord Injury; February 20–21, 2004; Vancouver, Canada. Spinal Cord. 2004;42(10):591–598.
Report of International Clinical Trials Workshop on Spinal Cord Injury; February 20–21, 2004; Vancouver, Canada
Spinal Cord
, vol. 
42
 (pg. 
591
-
598
)
Anderson DK, Beattie M, et al. Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord. 2005;43(8):453–458.
Recommended guidelines for studies of human subjects with spinal cord injury
Spinal Cord
, vol. 
43
 (pg. 
453
-
458
)
Raisman G. Repair of spinal cord injury: ripples of an incoming tide, or how I spent my first 40 years in research. Spinal Cord. 2006;44(7):406–413.
Repair of spinal cord injury: ripples of an incoming tide, or how I spent my first 40 years in research
Spinal Cord
, vol. 
44
 (pg. 
406
-
413
)
Young W. Spinal cord injury curative therapies in the pipeline, 2007. Available at: www.sciwire.com www.sciwire.com
Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med. 2006;29(3):191–203; discussion 204–196.
Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study
J Spinal Cord Med.
, vol. 
29
 (pg. 
191
-
203
)
Moviglia GA, Fernandez Vina R, Brizuela JA, et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy. 2006;8(3):202–209.
Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients
Cytotherapy
, vol. 
8
 (pg. 
202
-
209
)
Anstett P. Cell transplants help to reverse paralysis, 2003. Available at: http://www.sci-info-pages.com/2003/12/cell-transplantshelp-to-reverse.html http://www.sci-info-pages.com/2003/12/cell-transplantshelp-to-reverse.html
www.stemcellschina.com www.stemcellschina.com
Dobkin BH, Curt A, Guest J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair. 2006;20(1):5–13.
Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury
Neurorehabil Neural Repair
, vol. 
20
 (pg. 
5
-
13
)
Leuthardt EC, Schalk G, Moran D, Ojemann JG. The emerging world of motor neuroprosthetics: a neurosurgical perspective. Neurosurgery. 2006;59(1):1–14; discussion 11–14.
The emerging world of motor neuroprosthetics: a neurosurgical perspective
Neurosurgery
, vol. 
59
 (pg. 
1
-
14
)
Hochberg LR, Serruya MD, Friehs GM, et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. 2006;442(7099):164–171.
Neuronal ensemble control of prosthetic devices by a human with tetraplegia
Nature
, vol. 
442
 (pg. 
164
-
171
)
Australian Government Legislation Review. Prohibition of Human Cloning Act 2002 and the Research Involving Human Embryos Act 2002, Reports, Canberra, December 2005. Available at: http://www.lockhartreview.com.au/reports.html http://www.lockhartreview.com.au/reports.html
Pincock S. UK opens embryonic stem cell bank. Lancet. 2004;363(9423):1778.
UK opens embryonic stem cell bank
Lancet
, vol. 
363
 pg. 
1778
 
Australian Stem Cell Centre. The world’s largest stem cell dedicated research facility launched in Victoria [press release]. February 18, 2004. Available at: http://www.stemcellcentre.edu.au/media-centre_media-releases_detail.aspx?view=16 http://www.stemcellcentre.edu.au/media-centre_media-releases_detail.aspx?view=16
This content is only available as a PDF.